Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




Mar
23
Today In Oncology
Dietary Influence on Leukemia and Lymphoma Progression
Black Race Predicts Inferior Survival in AML Independent of Cytogenetic Risk
Three AI-Enabled Analyses Highlight Context-Dependent Biomarkers in Early-Onset Colorectal Cancer
Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis
The Thymus Plays a Part in Adult Cancer Risk and Treatment Response
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo